PapersPMID:31237183
The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- crossover · 98 participants · 7 days
- Dose studied, every finding
- L-tryptophan 1000 mg/day (two 500 mg capsules) 20 minutes before bedtime, versus placebo capsules (microcrystalline cellulose)
- Population, every finding
- Healthy adults aged 20 to 30 without sleep disorder or psychiatric diagnosis, homozygous 5-HTTLPR S'/S' (n = 47) and L'/L' (n = 51) carriers analysed together; double-blind placebo-controlled crossover, 1 week each
What moved
How to read these marks →“Linear mixed model analyses with treatment (tryptophan versus placebo) as a single predictor for objective sleep variables revealed a significant increase in sleep efficiency (b = 0.977, t(1027.10) = 3.337, p < 0.001) and a reduction in objective wake after sleep onset (b = −5.188, t(1027.83) = −3.502, p < 0.001) following tryptophan relative to placebo intake.”
- Increases sleep efficiency
moderate
Study record
- Design
- crossover trial
- Species
- human
- Population
- Young adults without psychiatric or sleep-disorder diagnosis, homozygous 5-HTTLPR S'/S' (n = 47) or L'/L' (n = 51); oral L-tryptophan 1000 mg/day for 1 week against 1 week of placebo, 20 minutes before bedtime
- Participants
- 98
- Comparator
- placebo
- Duration
- 7 days
- Endpoints measured
- 16
- Declined
- this platform holds no node for the endpoint